Valuation dashboard for Cigna Corporation (CI) with P/E 12.23, P/B 1.83, EV/EBITDA 8.2 and dividend yield 2.10%. DCF, Graham Number, EPS growth, peer multiples and dividend discount models plus sector comparison against other Healthcare companies.
Cigna Group, established in 1792 and headquartered in Bloomfield, Connecticut, provides insurance products and related services across the United States. The company operates through two primary segments. Its Evernorth division offers a comprehensive array of coordinated and specialized health solutions, including pharmacy services, benefits administration, care management and delivery, and advanced intelligence solutions.
Where would it trade at its usual multiples?
Versus its usual multiples: cheap · Current P/E 12.2× · Multiples range: $417.73 · $741.47.
At the decade median (17.3×) $418 (+41%); at its sector median (30.7×) $741 (+151%). Implied price from applying the reference multiples to today's earnings (or book value, or FFO) per share. Not a fair value: it is where the stock would trade at its usual multiples.
Analysis Summary
Cigna Corporation reported revenue of $274.95B in the most recent fiscal year, growing at a 5-year CAGR of 11.4%. Net income reached $5.96B, with a -6.8% 5-year CAGR.
Trailing-twelve-month margins: gross margin 11.7%, operating margin 3.5%, net margin 2.3%.
At $295.44 (closing price, November 3, 2026), CI trades at a P/E of 12.23 and an ROE of 15.24%. Market capitalisation stands at $78.1B, placing it among large-cap names.
Balance sheet quality for CI: debt-to-equity ratio of 0.75, current ratio of 0.85 over the last 12 months. A debt-to-equity below 1.0 typically signals conservative capital structure, while a current ratio above 1.5 indicates comfortable short-term liquidity.
Valuation Ratios
| P/E Ratio | 12.23 |
| Price / Book | 1.83 |
| EV / EBITDA | 8.2 |
| Dividend Yield | 2.10% |
Peer Comparison
| Symbol | Company | Market Cap | P/E | P/B | ROE |
|---|---|---|---|---|---|
| CI | Cigna Corporation | $78.1B | 12.23 | 1.83 | 15.2% |
| UNH | UnitedHealth Group Incorporated | $363.0B | 23.08 | 3.50 | 16.1% |
| CVS | CVS Health Corp. | $105.2B | 9.57 | 1.32 | 14.1% |
| ELV | Elevance Health Inc. | $89.7B | 17.64 | 2.01 | 11.6% |
| HUM | Humana Inc. | $50.2B | 39.57 | 2.61 | 6.9% |
| CNC | Centene Corp. | $33.4B | 23.11 | 1.48 | 6.8% |
| MOH | Molina Healthcare, Inc. | $10.8B | 2.58 | -1.2% | |
| OSCR | Oscar Health, Inc. | $8.4B | 23.15 | 4.57 | 38.5% |
Price
| Price | $295.44 (closing price, November 3, 2026) |
| Market Cap | $78.1B |
| Exchange | NYSE |
| Country | US |
Profitability
| Return on Equity | 15.24% |
| Return on Invested Capital | 7.69% |
| Return on Assets | 4.08% |
| Gross Margin | 11.66% |
| Operating Margin | 3.46% |
| Net Margin | 2.27% |
Related companies: UNH · CVS · ELV · HUM · CNC · MOH · OSCR
Explore sector: Healthcare · Medical - Healthcare Plans
More sections of CI: Overview · Financials · Estimates · Technical · Ownership
Discover more: Weekly Radar: the S&P 500 through the Buffett and Lynch methods · Companies that pass the Buffett method · Companies that pass the Lynch method · Stocks that pass Graham's defensive investor test today · Investment Academy — learn to analyze stocks